Skip to search formSkip to main contentSkip to account menu

Evaluable Disease

Known as: Evaluable 
Disease that cannot be measured directly by the size of the tumor but can be evaluated by other methods specific to a particular clinical trial.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
PURPOSE The purpose of this study is to evaluate HER-2 and topoisomerase IIalpha (topo IIalpha) as candidates for predicting the… 
Highly Cited
1999
Highly Cited
1999
BACKGROUND Rituximab is a chimeric monoclonal antibody directed against the B-cell CD20 antigen which has been utilized for… 
Review
1994
Review
1994
Paclitaxel is a new anticancer agent with a novel mechanism of action. It promotes polymerisation of tubulin dimers to form… 
Highly Cited
1992
Highly Cited
1992
A significant increase in the dose intensity of chemotherapy with fluoropyrimidines and platinum complexes has resulted from… 
Highly Cited
1991
Highly Cited
1991
One hundred and twenty-six patients were treated for 137 episodes of fungal infection with liposomal amphotericin B (AmBisome) at… 
Highly Cited
1990
Highly Cited
1990
The value of chemotherapy in advanced non-small cell lung cancer (NSCLC) remains contentious. Because of this two separate but… 
Highly Cited
1987
Highly Cited
1987
Busulfan 16 mg/kg and cyclophosphamide 120 mg/kg were used as conditioning prior to allogeneic marrow transplantation in 50 adult… 
Highly Cited
1977
Highly Cited
1977
A clinical trial was undertaken to improve the therapeutic index of cis‐plati‐num diammine dichloride with a concomitantly…